Cargando…
Will SARS-CoV-2 variants of concern affect the promise of vaccines?
Initial optimism regarding the development of COVID-19 vaccines has been tempered by the emergence of new variants of SARS-CoV-2. Will vaccination be able to contain the pandemic? How can we best optimize the limited supplies of vaccines available and what should future COVID-19 vaccines look like?
Autor principal: | Gupta, Ravindra K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082481/ https://www.ncbi.nlm.nih.gov/pubmed/33927376 http://dx.doi.org/10.1038/s41577-021-00556-5 |
Ejemplares similares
-
Author Correction: Will SARS-CoV-2 variants of concern affect the promise of vaccines?
por: Gupta, Ravindra K.
Publicado: (2021) -
SARS-CoV-2 evolution and vaccines: cause for concern?
por: Williams, Thomas C, et al.
Publicado: (2021) -
A promising inactivated whole-virion SARS-CoV-2 vaccine
por: Isakova-Sivak, Irina, et al.
Publicado: (2021) -
Managing waning vaccine protection against SARS-CoV-2 variants
por: Leung, Kathy, et al.
Publicado: (2022) -
SARS-CoV-2 delta variant: a persistent threat to the effectiveness of vaccines
por: Thiruvengadam, Ramachandran, et al.
Publicado: (2022)